Early Detection of Cardiac Toxicity of Trastuzumab (Herceptin ®) in Patients Treated for Breast Carcinoma: Value of Magnetic Resonance Imaging (MRTOX)

This study has been terminated.
(lack of recruitment)
Information provided by (Responsible Party):
Centre Francois Baclesse
ClinicalTrials.gov Identifier:
First received: September 15, 2011
Last updated: September 17, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)